Editas Medicine, Inc. (EDIT)
Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA.
Address
11 HURLEY ST.
CAMBRIDGE, MA 02141
Founded
2013
Number of Employees
265
Website
http://www.editasmedicine.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)